TGFB1 and breast cancer: One study applied the compound high-molecular-weight E. coli K5-derived heparin-like polysaccharide (UFH K5-NSOS) to a triple-negative MDA-MB-231 breast cancer cell model, wherein UFH K5-NSOS reduced IL-11 levels through TGF-β inhibition [57].